Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DA-8010 in Patients With Overactive Bladder [Phase 3]

View source ↗

Summary

Phase 3 study evaluating DA-8010 for overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• DA-8010

Snippet

Sponsor: Dong-A ST Co., Ltd. | Conditions: Overactive Bladder | Phase 3 | Status: COMPLETED